Name: NAMS Balance Sheet - Newamsterdam Pharma Co. Assets & Debt | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Total Assets, Current Assets, Cash and Equivalents, Total Liabilities, Long-term Debt, Short-term Debt, Shareholders Equity, Working Capital, Book Value Per Share

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

NAMS - Newamsterdam Pharma Co. NV

USD | NASDAQ | Healthcare

NAMS Balance Sheet - Newamsterdam Pharma Co. Assets & Debt | Ledgeburg

(in millions of USD)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q4 FY 21	Q4 FY 20
Cash And Short Term Investments
Cash And Equivalents	457.6	490.0	538.4	563.9	748.4	771.7	422.7	-	-	-	-	-	-	-	-	-
Restricted Cash	1.3	1.3	1.3	-	-	-	-	-	-	-	-	-	-	-	-	-
Short Term Investments	178.5	146.2	164.5	175.3	60.1	62.4	-	-	-	-	-	-	-	-	-	-
Cash And Short Term Investments	636.1	636.2	702.9	739.2	808.5	834.2	422.7	-	-	-	-	-	-	-	-
Receivables
Accounts Receivable	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Current Assets
Inventory	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non-Current Assets
Property, Plant & Equipment Gross	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Current Liabilities
Accounts Payable	8.1	9.0	3.6	5.9	6.1	4.7	7.0	5.3	8.5	16.9	-	-	-	-	-
Non-Current Liabilities
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Common Equity
Common Stock	14.6	14.3	14.1	14.0	14.0	13.4	11.4	11.2	11.1	10.2	-	-	-	-	-	-
Supplementary Data
Total Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD)	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020
Cash And Short Term Investments
Cash And Equivalents	490.0	771.7	340.5	-	-	-
Restricted Cash	1.3	-	-	-	-	-
Short Term Investments	146.2	62.4	-	-	-	-
Cash And Short Term Investments	636.2	834.2	340.5	-	-	-
Receivables
Accounts Receivable	-	-	-	-	-	-
Current Assets
Inventory	-	-	-	-	-	-
Prepaid Expenses	38.1	24.3	6.3	10.3	-	-
Other Current Assets
Non-Current Assets
Property, Plant & Equipment Gross	-	-	-	-	-	-
Accumulated Depreciation	-	-	-	-	-	-
Current Liabilities
Accounts Payable	9.0	4.7	16.9	11.9	-	-
Short Term Debt	-	-	-	-	-	-
Deferred Revenue Current
Non-Current Liabilities
Long Term Debt	-	-	-	-	-	-
Operating Lease Liabilities Non-Current	0.1	0.2	-	0.1	-	-
Common Equity
Common Stock	14.3	13.4	10.2	10.1	-	-
Additional Paid In Capital	-	-	-	-	-	-
Retained Earnings
Supplementary Data
Total Debt	-	-	-	-	-	-
Net debt	-	-	-	-	-	-
Working Capital

Source: SEC EDGAR company filings. Figures as reported (US GAAP)